Bryan Love to Biosimilar Pharmaceuticals
This is a "connection" page, showing publications Bryan Love has written about Biosimilar Pharmaceuticals.
Connection Strength
0.277
-
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada. Oncologist. 2019 04; 24(4):537-548.
Score: 0.159
-
Regulatory and clinical considerations for biosimilar oncology drugs. Lancet Oncol. 2014 Dec; 15(13):e594-e605.
Score: 0.118